Aspects of drug development and clinical trials

Abstract

Get full access to this article

View all access options for this article.

References

Hossain P. , Kawar B. , El Nahas M. Obesity and diabetes in the developing world - a growing challenge. N Engl J Med 2007;356:213-15.

Haslam D. , Sattar N. , Lean M. ABC of obesity: Obesity-time to wake up. BMJ 2006;333:640-2.

Padwal RS , Majundar SR Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 2007;369:71-7.

The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes and cardiovascular diseases: executive summary. Eur Heart J 2007;28:88-136.

Nathan DM , Davidson M. , DeFronzo RA et al. Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for Care. A Consensus Statement from the American Diabetes Association. Diabetes Care 2007;30:753-9.

Alberti Kgmm , Zimmet P. , Shaw J. International Diabetes Federation (IDF): a consensus on type 2 diabetes prevention. Diabet Med 2007;24:451-63.

Marshall SM , Flyvbjerg A. Prevention and early detection of vascular complications of diabetes. BMJ 2006;333:475-80.

Aspects of drug development and clinical trials — Part 1

Abstract

Get full access to this article

References